XML 35 R17.htm IDEA: XBRL DOCUMENT v3.25.2
Equity Compensation and Other Benefits
 6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Compensation and Other Benefits Equity Compensation and Other Benefits
The Company's stock-based plans are described and informational disclosures are provided in the Notes to the Consolidated Financial Statements included in the Annual Report.
Stock-based Compensation - Total stock-based compensation expense included in the Condensed Consolidated Statements of Operations (Unaudited) is as follows:
Three Months Ended June 30,Six Months Ended June 30,
(in thousands)2025202420252024
Technology and facilities$758 $769 $1,474 $1,928 
Sales and marketing35 29 75 53 
Personnel1,915 2,144 3,990 4,943 
Total stock-based compensation (1)
$2,708 $2,942 $5,539 $6,924 
(1) Amounts shown are net of $0.2 million and $0.4 million of capitalized stock-based compensation for the three and six months ended June 30, 2025, respectively, and net of $0.2 million and $0.5 million of capitalized stock-based compensation for the three and six months ended June 30, 2024, respectively.

As of June 30, 2025, and December 31, 2024, the Company’s total unrecognized compensation cost related to unvested stock-based option awards granted to employees was $0.5 million and $0.9 million, respectively, which will be recognized over a weighted-average vesting period of approximately 0.9 years and 1.3 years, respectively. As of June 30, 2025 and December 31, 2024, the Company's total unrecognized compensation cost related to time-based and performance-based unvested restricted stock unit awards granted to employees was $19.3 million and $15.3 million, respectively, which will be recognized over a weighted average vesting period of approximately 2.0 years and 2.0 years, respectively.
Cash flows from the tax benefits for tax deductions resulting from the exercise of stock options in excess of the compensation expense recorded for those options (excess tax benefits) are required to be classified as cash from financing activities. The Company recognized $1.6 million and $2.0 million of income tax benefit in its Condensed Consolidated Statements of Operations (Unaudited) related to stock-based compensation expense during the six months ended June 30, 2025 and 2024, respectively. Additionally, the total income tax benefit recognized in the income statement for share-based compensation exercises was $0.1 million and $0.3 million for the three and six months ended June 30, 2025, respectively. The total income tax expense recognized in the income statement for share-based compensation exercises was $0.2 million and $1.7 million for the three and six months ended June 30, 2024, respectively.